Singapore markets closed

Adamis Pharmaceuticals Corporation (ADMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6000-0.0008 (-0.13%)
At close: 04:00PM EST
0.6000 0.00 (0.00%)
After hours: 07:17PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 100.96M
Enterprise value 73.00M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)4.97
Price/book (mrq)2.93
Enterprise value/revenue 4.10
Enterprise value/EBITDA -1.49

Trading information

Stock price history

Beta (5Y monthly) 1.23
52-week change 3-65.12%
S&P500 52-week change 314.07%
52-week high 31.8000
52-week low 30.5500
50-day moving average 30.7180
200-day moving average 30.9143

Share statistics

Avg vol (3-month) 33.04M
Avg vol (10-day) 35.42M
Shares outstanding 5148.89M
Implied shares outstanding 6N/A
Float 8147.67M
% held by insiders 10.96%
% held by institutions 110.16%
Shares short (30 Dec 2021) 47.99M
Short ratio (30 Dec 2021) 44.87
Short % of float (30 Dec 2021) 45.40%
Short % of shares outstanding (30 Dec 2021) 45.37%
Shares short (prior month 29 Nov 2021) 49.02M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:17
Last split date 312 Dec 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-228.83%

Management effectiveness

Return on assets (ttm)-57.21%
Return on equity (ttm)-168.76%

Income statement

Revenue (ttm)17.8M
Revenue per share (ttm)0.14
Quarterly revenue growth (yoy)-12.50%
Gross profit (ttm)1.63M
EBITDA -37.85M
Net income avi to common (ttm)-52.2M
Diluted EPS (ttm)-0.4210
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)28.73M
Total cash per share (mrq)0.19
Total debt (mrq)775.75k
Total debt/equity (mrq)2.25
Current ratio (mrq)4.56
Book value per share (mrq)0.23

Cash flow statement

Operating cash flow (ttm)-36.55M
Levered free cash flow (ttm)-28.99M